Apogee Therapeutics
Apogee Therapeutics is hiring a Director of Drug Product Development to lead development of biologic drug product presentations and ensure reliable drug product supply to support clinical trials through commercialization. The role sits within the Formulation and Drug Product Development group and partners closely with internal CMC stakeholders and external CDMOs to advance prefilled syringe and other delivery formats.
Headquarters
San Francisco, California, United States
Company Size
51-200 employees
Founded
2022
Apogee Therapeutics is a clinical-stage biotechnology company developing differentiated biologics for immunological and inflammatory diseases. The company focuses on high-unmet-need conditions including atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), asthma and other I&I disorders. Apogee advances therapeutic candidates through clinical development with the goal of delivering best‑in‑class treatments for patients with inflammatory and immune-mediated diseases.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Apogee Therapeutics.
A Look At Apogee Therapeutics (APGE) Valuation After Wider Losses And A New Shelf Registration
2 days ago
Associate Director, Drug Product
Spyre Therapeutics
(Associate) Director, Drug Product, CMC
Centessa Pharmaceuticals
Director, CMC Product Development – Biologics
Beeline Medicines
Associate Director/Director, Drug Product -CMC
Monte Rosa Therapeutics, Inc
Director, Drug Product
Enliven
Senior Director of Drug Product
Centessa Pharmaceuticals